Latest filing published 01 Jun 2026 for Acadia Pharmaceuticals INC. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Adora Ndu across 2 companies, led by Acadia Pharmaceuticals Inc and DBV Technologies S.A. Between 12 October 2023 and 29 May 2026, the trades on record add up to 6 filings.
The open-market record is one-sided, with 1 purchase worth €1,512 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 option exercises.
The record was last updated on 1 June 2026 with an option exercise in Acadia Pharmaceuticals Inc. The last purchase on record was published on 8 February 2024, which is 983 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations